NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
12/17/2024
Back to search
Official data from USPTO
ENVISION PHARMA GROUP
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ENVISION PHARMA GROUP
ST13
US500000086278128Class
35, 41, 42, 45
Filing
86278128
Registration
4775303
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
01/07/2025
Trademark type
Word
Nice classes
35, 41, 42, 45
Filing date
05/12/2014
Registration date
07/21/2015
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/17/2024
Last transaction
01/07/2025
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
06/07/2013
First use in commerce
06/07/2013
Drawing code
4
Owner type
03
Owner location
Fairfield, CT
Examiner
SAITO, KIM
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
ENVISION PHARMA INC.
ENVISION PHARMA INC.
Representatives
Zachary A. Aria Blank Rome LLP
Technical classification
Nice Classes
Class 35Class 41Class 42Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Strategic business consulting services for the life sciencepharmaceutical and bio-pharmaceutical industries in the field of health economics and outcomes research; Strategic business marketing consulting services for the life sciencepharmaceutical and bio-pharmaceutical industries in the field of market access communication strategies; Strategic business consulting services for the life sciencepharmaceutical and bio-pharmaceutical industries in the field of medical and scientific publication planning
Class 41
Strategic educational consulting services for the life sciencespharmaceutical and bio-pharmaceutical industries in the field of medical educationcontinuing professional educational courses and meetings for Medical Science Liaisons
Class 42
Medical and scientific publication planning in the nature of technical writing for others related to pharmaceutical and bio-pharmaceutical products; Design and implementation of software and technology solutions for the life sciencepharmaceutical and bio-pharmaceutical industriesfor the purpose of creatingcommunicatingreporting and auditing of scientific information to be publicly disclosed; Design and implementation of software and technology solutions for the life sciencepharmaceutical and bio-pharmaceutical industriesfor use in grant programs that manages investigator sponsored researchproduct requestsfunding requestsdonation requestsdecision process workflowactivity monitoringmanagement of contractual obligations
Class 45
Strategic consulting services for the life sciencepharmaceutical and bio-pharmaceutical industries in the nature of regulatory compliance consulting in the field of pharmaceutical and bio-pharmaceutical products
Publications
History of USPTO decisions and trademark events.
35 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
12/17/2024
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
12/17/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/17/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
09/09/2024
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
07/21/2024
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
10/16/2021
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
10/16/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/16/2021
E815
TEAS SECTION 8 & 15 RECEIVED
07/07/2021
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
07/21/2020
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
12/13/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/13/2019
ES7R
TEAS SECTION 7 REQUEST RECEIVED
11/07/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/07/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/07/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/07/2019
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
11/07/2019
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
11/07/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
07/21/2015
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/05/2015
PUBO
PUBLISHED FOR OPPOSITION
05/05/2015
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/15/2015
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
03/27/2015
ALIE
ASSIGNED TO LIE
03/27/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/08/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/24/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/24/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/24/2015
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/03/2014
GNRT
NON-FINAL ACTION E-MAILED
09/03/2014
CNRT
NON-FINAL ACTION WRITTEN
09/03/2014
DOCK
ASSIGNED TO EXAMINER
08/26/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/22/2014
NWAP
NEW APPLICATION ENTERED
05/15/2014
Continuous trademark protection
Get notified about every new filing that threatens ENVISION PHARMA GROUP or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.